GSK

GSK recalls acidity tablet Zinetac amid concerns over cancer-causing contaminants

September 26, 2019 3:13 pm

Zinetac medicine recalled: Ranitidine, a medicine that decreases stomach acid production, had a market size of Rs 688.6 crore in India and Zinetac was the second largest brand in this segment as of August 2019, according to AIOCD Awacs PharmaTrac.

UK fraud office expects decision on GSK, Rolls-Royce cases next year

August 10, 2017 10:16 pm

David Green, the head of the UK Serious Fraud Office, told Reuters in an interview that he hoped a decision about charges would be made before he steps down after six years in the job next April.

GSK, Pfizer other global pharma companies too come under USFDA net

May 10, 2014 8:53 am

Not all FDA regulatory action is targeted at Indian drug makers; global pharma majors fined too.

GSK recalls weight-loss drug in US on tampering concerns

March 28, 2014 2:10 am

The British group said it believed that some US bottles of Alli might not contain authentic product.

Maruti to focus on rural market

December 25, 2013 1:58 am

Maruti Suzuki India (MSI) is driving into the rural markets to boost sales.

GSK to spend $1 bn to hike stake in India unit

December 17, 2013 2:08 am

GSK is planning to hike its stake in the Indian unit to up to 75 per cent from 50.67 per cent.

Quarterly results: GSK Consumer Q3 net up 14.29%

November 07, 2013 2:47 am

GSK reported 14.29 per cent increase in standalone net profit at Rs 146.93 crore.

China probe: GSK’s local executives may face charges; steps against firm unlikely

November 05, 2013 2:35 am

GlaxoSmithKline Pharma hit by Nomura downgrade

June 10, 2013 2:53 pm

GlaxoSmithKline Pharmaceuticals Ltd shares dropped 4.3 per cent.

Consumer sector: Premium rush

September 03, 2012 3:48 am

Rural income growth and aspirational buys of lower income groups to sustain growth momentum.